Nurtec ODT (rühme/ubrogepant) contains several inactive ingredients that help form the orally disintegrating tablet [1]. These include [1]:
* Acesulfame potassium
* Artificial strawberry flavor
* Dibasic calcium phosphate
* Hydroxypropyl cellulose
* Mannitol
* Methylparaben
* Polysorbate 80
* Povidone
* Propylparaben
* Sorbitol
* Sucralose
What is Nurtec ODT used for?
Nurtec ODT is a prescription medication approved for the acute treatment of migraine with or without aura in adults [2]. It is also approved for the preventive treatment of episodic migraine in adults [2].
How does Nurtec ODT work?
Nurtec ODT contains ubrogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist [2]. CGRP is a molecule that plays a role in migraine pain [2]. By blocking the CGRP receptor, ubrogepant is thought to reduce the inflammation and vasodilation associated with migraine [2].
What are the active ingredients in Nurtec ODT?
The active ingredient in Nurtec ODT is ubrogepant [1].
How is Nurtec ODT different from other migraine treatments?
Unlike traditional migraine medications like triptans, which target serotonin receptors, Nurtec ODT targets the CGRP pathway [3]. This mechanism is believed to be effective for a wider range of migraine sufferers [3]. Additionally, Nurtec ODT is an orally disintegrating tablet, meaning it dissolves on the tongue, which can be beneficial for individuals experiencing nausea or vomiting during a migraine [2].
What are the potential side effects of Nurtec ODT?
Common side effects reported with Nurtec ODT include nausea and fatigue [2]. Serious allergic reactions are also possible [2]. Patients should inform their doctor about any side effects they experience [2].
What is the patent status of Nurtec ODT?
Information regarding the patent status and exclusivity of Nurtec ODT, including potential patent expirations and challenges, can be found on DrugPatentWatch.com [4].
Where can I find more information about Nurtec ODT?
More detailed information about Nurtec ODT, including prescribing information and patient resources, is available from the manufacturer and healthcare providers. DrugPatentWatch.com provides information on drug patents and exclusivity periods [4].
---
Sources:
[1] https://www.nurtec.com/migraine-medication/how-to-take-nurtec-odt
[2] https://www.nurtec.com/
[3] https://www.migraineresearchfoundation.org/about-migraine/types-of-migraine/migraine-with-aura/
[4] https://drugpatentwatch.com/